Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway

BACKGROUND: Mesenchymal stem cell (MSC)-derived exosomes emerge as promising candidates for treating delayed wound healing in diabetes due to the promotion of angiogenesis. Preconditioned MSC with chemical or biological factors could possibly enhance the biological activities of MSC-derived exosomes...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Stem Cell Res Ther
Main Authors: Yu, Muyu, Liu, Wei, Li, Junxian, Lu, Junxi, Lu, Huijuan, Jia, Weiping, Liu, Fang
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425015/
https://ncbi.nlm.nih.gov/pubmed/32787917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01824-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki